S
Spero Therapeutics (SPRO)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Spero Therapeutics (SPRO)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more
- USD1.90
- USD2.01
- USD1.90
- USD3.22
- -0.50%
- 49M
- 273.19k
- 569.68k
- 107M
- 0.51
- 42.90%
Stock News
yesterday
Treasury yields rise after Fed rate cut, with Powell in no ‘sprint’ to loosen policy
MarketWatch
yesterday
Comcast spinoff Versant reports declining annual profit as it prepares to go public
CNBC
yesterday
What Kevin Durant would tell an NBA rookie who wants to follow in his footsteps
CNBC
yesterday
Here's a rapid fire update on all 31 portfolio stocks including our newest name
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
